Tot 100% vermindering van myopieprogressie1 1. In 21.5% of the cases among children wearing MiYOSMART spectacle lens, during a 2-year randomized controlled clinical trial, no myopia progression was observed. Lam CSY, Tang WC, TseDY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739 2. Jong M, Jonas JB, Wolffsohn JS, et al. IMI 2021 Yearly Digest. Invest. Ophthalmol. Vis. Sci. 2021;62(5):7. https://doi.org/10.1167/iovs.62.5.7 Gerapporteerd als effectieve optie voor myopie management door het International Myopia Institute.2 www.hoyavision.com/nl/brillenglazen/miyosmart/ MiYOSMART: het slimme brillenglas voor behandeling van progressieve myopie
RkJQdWJsaXNoZXIy MTAyNDU4